Share the post "Shareholding Pattern: Shareholding Pattern Vivanza Biosciences FY(Q2-Sep 2024-2025)"
Vivanza Biosciences has released its latest shareholding reports, covering the Second quarter and the fiscal year ending on (Q2-Sep 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
Shareholder Name |
Previous Quater Quantity(In Crores) |
Current Quater Quantity(In Crores) |
Previous Quater Shares(in %) |
Current Quater Shares(in %) |
Quater to Quater Difference |
Promoters |
1.60 |
1.59 |
40.05 |
39.86 |
-0.19 % |
Public |
2.40 |
2.41 |
59.95 |
60.14 |
+0.19 % |
DII
|
0.00 |
0.00 |
0 |
0 |
0 |
FII
|
0 |
0 |
0 |
0 |
0 |
Government
|
0 |
0 |
0 |
0 |
0 |
Promoters’ shareholding decreased from 40.05% in June 2024 to 39.86% in September 2024. This reduction indicates that the promoters’ control over Company has weakened during this period.The percentage of shares held by the public increased from 59.95% in June 2024 to 60.14% in September 2024.This change suggests that the public’s investment in the company grew during the quarter.DIIs (Domestic Institutional Investors) shareholding remained unchanged at 0% from June 2024 to September 2024. This indicates that domestic institutions maintained their investment level in the company.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
Shareholder Name |
Previous Quarter Quantity (In crores) |
Current Quarter Quantity (In crores) |
Previous Quarter Shares (in %) |
Current Quarter Shares (in %) |
Quarter-to-Quarter Difference (%) |
PARTH HEMANT PARIKH |
1.592 |
1.585 |
39.8 |
39.61 |
-0.19 % |
PARTH HEMANT PARIKH faced a downturn in stakeholding this quarter, witnessing a decline of -0.19 % in stakeholding compared to the previous quarter.
Shareholder Name |
Previous Quarter Quantity (In Crores) |
Current Quarter Quantity (In Crores) |
Previous Quater Shares (in %) |
Current Quater Shares (in %) |
Quater-to-Quater Difference (%) |
Resident Individuals holding nominal share capital up to Rs. 2 lakhs |
1.741 |
1.939 |
43.53 |
48.47 |
+ 4.94 % |
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs |
0.059 |
0.103 |
1.48 |
2.58 |
+ 1.1 % |
Non Resident Indians (NRIs) |
0.015 |
0.031 |
0.37 |
0.76 |
+ 0.39 % |
Bodies Corporate |
0.568 |
0.315 |
14.21 |
7.87 |
-6.34 % |
ASHOKA METCAST LIMITED |
0.563 |
0.310 |
14.08 |
7.75 |
-6.33 % |
Any Other (specify) |
0.013 |
0.017 |
0.33 |
0.42 |
+ 0.09 % |
HUF |
0.013 |
0.017 |
0.33 |
0.42 |
+ 0.09 % |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 4.94 %.Leading the way to higher stakeholding, Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs has significantly boosted stakeholding by an impressive 1.1 %.Leading the way to higher stakeholding, Non Resident Indians (NRIs) has significantly boosted stakeholding by an impressive 0.39 %.Observations show a significant difference of -6.34 % in Bodies Corporate’s financial performance between quarters.Observations show a significant difference of -6.33 % in ASHOKA METCAST LIMITED’s financial performance between quarters.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.09 %.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.09 %.
[my_shortcode1 values=”Vivanza Biosciences”]